Reclassification of marijuana opens doors for much‑needed medical research into the benefits and risks of the drug
When the U.S. Department of Justice moved to reclassify medical marijuana to a Schedule III drug on April 23, 2026, it set the stage for a vast amount of medical research that has been hobbled for decades by its more restrictive ...
Apr 29, 2026
0
6









